COX-2 expression of ampullary carcinoma: Correlation with different histotypes and clinicopathological parameters

Virchows Archiv

Volumn 449, Issue 3, 2006, Pages 334-340

  Perrone, Giuseppe ^a   Santini, Daniele ^b   Zagami, Mariagiovanna ^a   Vincenzi, Bruno ^b   Verzì, Alfio ^a   Morini, Sergio ^c   Borzomati, Domenico ^d   Coppola, Roberto ^d   Antinori, Armando ^e   Magistrelli, Paolo ^e   Tonini, Giuseppe ^b   Rabitti, Carla ^a  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b Oncology Unit   (Italy)

^c NONE   (Italy)

^d University Campus Bio Medico di Roma   (Italy)

^e CATHOLIC UNIVERSITY   (Italy)

Author keywords

Ampulla; Cancer; COX 2; Histotype; Vater

Indexed keywords

CYCLOOXYGENASE 2;

ADULT; AGED; ARTICLE; CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; VATER PAPILLA;

ADENOCARCINOMA; ADULT; AGED; AMPULLA OF VATER; COMMON BILE DUCT NEOPLASMS; CYCLOOXYGENASE 2; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPH NODES; MALE; MIDDLE AGED;

EID: 33748536096     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-006-0255-9     Document Type: Article

References (41)

1. Agoff SN, Crispin DA, Bronner MP, Dail DH, Hawes SE, Haggitt RC (2001) Neoplasms of the ampulla of vater with concurrent pancreatic intraductal neoplasia: a histological and molecular study. Mod Pathol 14:139-146
2. Albores-Saavedra J, Henson DE, Klimstra DS (2000) Tumors of the gallbladder, extrahepatic bile duct, and ampulla of Vater. In: Rosai J, Sobin L (eds) Atlas of tumor pathology, 3rd series, fascicle 27. Armed Forces Institute of Pathology, Washington DC, pp 259-316
3. Altorki NK, Subbaramaiah K, Dannenberg AJ (2004) COX-2 inhibition in upper aerodigestive tract tumors. Semin Oncol 31:30-35
4. Callejas NA, Casado M, Diaz-Guerra MJ, Bosca L, Martin-Sanz P (2001) Expression of cyclooxygenase-2 promotes the release of matrix metalloproteinases-2 and -9 in fetal rats hepatocytes. Hepatology 33:860-867
5. Cianchi F, Cortesini C, Bechi P, Fantappie O, Messerini L, Vannacci A, Sardi I, Baroni G, Boddi V, Mazzanti R, Masini E (2001) Up-regulation of cyclooxygenase 2 gene expression correlates with tumor angiogenesis in human colorectal cancer. Gastroenterology 121:1339-1347
6. Daniel TO, Liu H, Morrow JD, Crews BC, Marnett LJ (1999) Thromboxane A2 is a mediator of cyclooxygenase-2 dependent endothelial migration and angiogenesis. Cancer Res 59:4574-4577
7. Dannenberg AJ, Altorki NK, Boyle JO, Dang C, Howe LR, Weksler BB, Subbaramaiah K (2001) Cyclooxygenase-2: a pharmacological target for the prevention of cancer. Lancet Oncol 2:544-551
8. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN (1994) Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107:1183-1188
9. Ferrara N, Gerber HP, LeCouter J (2003) The biology of VEGF and its receptors. Nat Med 9:669-676
10. Fischer HP, Zhou H (2004) Pathogenesis of carcinoma of the papilla of Vater. J Hepatobiliary Pancreat Surg 11:301-309
11. Gately S, Li WW (2004) Multiple roles of COX-2 in tumor angiogenesis: a target for antiangiogenic therapy. Semin Oncol 31:2-11
12. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57-70
13. Harris RE, Namboodiri KK, Farrar WB (1996) Nonsteroidal antiinflammatory drugs and breast cancer. Epidemiology 7:203-205
14. Inoue H, Takamori M, Shimoyama Y, Ishibashi H, Yamamoto S, Koshihara Y (2002) Regulation by PGE2 of the production of interleukin-6, macrophage colony stimulating factor, and vascular endothelial growth factor in human synovial fibroblasts. Br J Pharmacol 136:287-295
15. Johnson TW, Anderson KE, Lazovich D, Folsom AR (2002) Association of aspirin and nonsteroidal anti-inflammatory drug use with breast cancer. Cancer Epidemiol Biomarkers Prev 11:1586-1591
16. Kim HJ, Sohn TS, Lee KT, Lee JK, Paik SW, Rhee JC (2003) Expression of cyclooxygenase-2 and its correlation with clinicopathologic factors of ampulla of Vater cancer. J Korean Med Sci 18:218-224
17. Kimura W, Ohtsubo K (1988) Incidence, sites of origin, and immunohistochemical and histochemical characteristics of atypical epithelium and minute carcinoma of the papilla of Vater. Cancer 61:1394-1402
18. Kimura W, Futakawa N, Yamagata S, Wada Y, Kuroda A, Muto T, Esaki Y (1994) Different clinicopathologic findings in two histologic types of carcinoma of papilla of Vater. Jpn J Cancer Res 85:161-166
19. Matsubayashi H, Watanabe H, Yamaguchi T, Ajioka Y, Nishikura K, Kijima H, Saito T (1999) Differences in mucus and K-ras mutation in relation to phenotypes of tumors of the papilla of Vater. Cancer 86:596-607
20. Murohara T, Horowitz JR, Silver M, Tsurumi Y, Chen D, Sullivan A, Isner JM (1998) Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation 97:99-107
21. Nelson AR, Fingleton B, Rothenberg ML, Matrisian LM (2000) Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol 18:1135-1149
22. Okami J, Yamamoto H, Fujiwara Y, Tsujie M, Kondo M, Noura S, Oshima S, Nagano H, Dono K, Umeshita K, Ishikawa O, Sakon M, Matsuura N, Nakamori S, Monden M (1999) Overexpression of cyclooxygenase-2 in carcinoma of the pancreas. Clin Cancer Res 5:2018-2024
23. Perrone G, Santini D, Verzi A, Vincenzi B, Borzomati D, Vecchio F, Coppola R, Antinori A, Magistrelli P, Tonini G, Rabitti C (2006) COX-2 expression in ampullary carcinoma: correlation with angiogenesis process and clinicopathological parameters. J Clin Pathol 59(5):492-496
24. Perrone G, Santini D, Vincenzi B, Zagami M, La Cesa A, Bianchi A, Altomare V, Primavera A, Battista C, Vetrani A, Tonini G, Rabitti C (2005) COX-2 expression in DCIS: correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological features. Histopathology 46:561-568
25. Ristimaki A, Honkanen N, Jankala H, Sipponen P, Harkonen M (1997) Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res 57:1276-1280
26. Rosai J (2004) Appendix E. In: Rosai and Ackerman's surgical pathology, 9th edn. Mosby, Edinburgh, pp 2953-2954
27. Rosenberg L, Palmer JR, Zauber AG, Warshauer ME, Stolley PD, Shapiro S (1991) A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. J Natl Cancer Inst 83:355-358
28. Santini D, Vincenzi B, Tonini G, Scarpa S, Vasaturo F, Malacrino C, Vecchio F, Borzomati D, Valeri S, Coppola R, Magistrelli P, Nuzzo G, Picciocchi A (2005) Cyclooxygenase-2 overexpression is associated with a poor outcome in resected ampullary cancer patients. Clin Cancer Res 11:3784-3789
29. Sheng H, Shao J, Morrow JD, Beauchamp RD, DuBois RN (1998) Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res 58:362-366
30. Smith WL, DeWitt DL, Garavito RM (2000) Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem 69:145-182
31. Sobin LH, Wittekind C (2002) TNM Classification of malignant tumours, 6th edn. UICC International Union Against Cancer, Wiley-Liss, New York
32. Stolina M, Sharma S, Lin Y, Dohadwala M, Gardner B, Luo J, Zhu L, Kronenberg M, Miller PW, Portanova J, Lee JC, Dubinett SM (2000) Specific inhibition of cyclooxygenase-2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis. J Immunol 164:361-370
33. Subbaramaiah K, Telang N, Ramonetti JT, Araki R, DeVito B, Weksler BB, Dannenberg AJ (1996) Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells. Cancer Res 56:4424-4429
34. Thun MJ, Namboodiri MM, Heath CW Jr (1991) Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 325:1593-1596
35. Voest EE, Kenyon BM, O'Reilly MS, Truitt G, D'Amato RJ, Folkman J (1995) Inhibition of angiogenesis in vivo by interleukin-12. J Natl Cancer Inst 87:581-586
36. Wang D, Mann JR, DuBois RN (2005) The role of prostaglandins and other eicosanoids in the gastrointestinal tract. Gastroenterology 128:1445-1461
37. Weidner N (2000) Angiogenesis as a predictor of clinical outcome in cancer patients. Hum Pathol 31:403-405
38. Wolff H, Saukkonen K, Anttila S, Karjalainen A, Vainio H, Ristimaki A (1998) Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Res 58:4997-5001
39. Zhao B, Kimura W, Futakawa N, Muto T, Kubota K, Harihara Y, Takayama T, Makuuchi M (1999) p53 and p21/Waf1 protein expression and K-ras codon 12 mutation in carcinoma of the papilla of Vater. Am J Gastroenterol 94:2128-2134
40. Zhou H, Schaefer N, Wolff M, Fischer HP (2004) Carcinoma of the ampulla of Vater: comparative histologic/immunohistochemical classification and follow-up. Am J Surg Pathol 28:875-882
41. Zimmermann KC, Sarbia M, Weber AA, Borchard F, Gabbert HE, Schror K (1999) Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res 59:198-204